Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


28.05.2018

2 AJR Am J Roentgenol
2 BJU Int
1 BMC Urol
4 Cancer
1 Clin Cancer Res
1 Eur Urol
1 J Clin Oncol
2 J Magn Reson Imaging
1 J Natl Cancer Inst
6 J Urol
1 PLoS Genet
2 Prog Urol
3 Radiology
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ORTMAN M, Kasson M, Sidana A
    Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2018;210:W268.
    PubMed     Text format    

  2. SHERIDAN AD, Weinreb JC, Spektor M
    Reply to "Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI".
    AJR Am J Roentgenol. 2018;210:W269.
    PubMed     Text format    


    BJU Int

  3. LOEB S, Taneja S, Walter D, Zweifach S, et al
    Crowd-Funding for Prostate Cancer and Breast Cancer.
    BJU Int. 2018 May 22. doi: 10.1111/bju.14408.
    PubMed     Text format     Abstract available

  4. ALI A, Hoyle A, Mistry H, Clarke NW, et al
    The importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
    BJU Int. 2018 May 19. doi: 10.1111/bju.14400.
    PubMed     Text format     Abstract available


    BMC Urol

  5. HUANG Q, Jiang P, Feng L, Xie L, et al
    Pre- and intra-operative predictors of postoperative hospital length of stay in patients undergoing radical prostatectomy for prostate cancer in China: a retrospective observational study.
    BMC Urol. 2018;18:43.
    PubMed     Text format     Abstract available


    Cancer

  6. FILSON CP
    Moving toward a more rational, evidence-based approach to PSA screening, diagnosis, and treatment of prostate cancer.
    Cancer. 2018 May 21. doi: 10.1002/cncr.31332.
    PubMed     Text format    

  7. NEGOITA S, Feuer EJ, Mariotto A, Cronin KA, et al
    Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Cancer. 2018 May 22. doi: 10.1002/cncr.31549.
    PubMed     Text format     Abstract available

  8. THOMPSON IM JR
    The pendulum swings back: Screening for prostate cancer in 2018.
    Cancer. 2018 May 22. doi: 10.1002/cncr.31555.
    PubMed     Text format    

  9. KEARNS JT, Holt SK, Wright JL, Lin DW, et al
    PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Cancer. 2018 May 21. doi: 10.1002/cncr.31337.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. HAYASHI T, Fujita K, Nojima S, Hayashi Y, et al
    High-fat Diet-induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling.
    Clin Cancer Res. 2018 May 18. pii: 1078-0432.CCR-18-0106.
    PubMed     Text format     Abstract available


    Eur Urol

  11. DONOVAN JL, Hamdy FC
    Time for a "Radical" Change to Active Surveillance for Prostate Cancer?
    Eur Urol. 2018 May 17. pii: S0302-2838(18)30357.
    PubMed     Text format    


    J Clin Oncol

  12. SPRATT DE, Carroll PR
    Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy?
    J Clin Oncol. 2018 May 21:JCO2018786236. doi: 10.1200/JCO.2018.78.6236.
    PubMed     Text format    


    J Magn Reson Imaging

  13. HECTORS SJ, Besa C, Wagner M, Jajamovich GH, et al
    DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    J Magn Reson Imaging. 2017 Jan 16. doi: 10.1002/jmri.25631.
    PubMed     Text format     Abstract available

  14. SABOURI S, Fazli L, Chang SD, Savdie R, et al
    MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.
    J Magn Reson Imaging. 2017 Jan 27. doi: 10.1002/jmri.25624.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  15. YARMOLINSKY J, Bonilla C, Haycock PC, Langdon RJQ, et al
    Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2018 May 17. pii: 4996958. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Urol

  16. GRIEBLING TL
    Re: Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.
    J Urol. 2018;199:1373-1376.
    PubMed     Text format    

  17. TANEJA SS
    Re: Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-Effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).
    J Urol. 2018;199:1397-1398.
    PubMed     Text format    

  18. TANEJA SS
    Re: Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
    J Urol. 2018;199:1396-1398.
    PubMed     Text format    

  19. GRIEBLING TL
    Re: Potential Overtreatment among Men Aged 80 Years and Older with Localized Prostate Cancer in Japan.
    J Urol. 2018;199:1375.
    PubMed     Text format    

  20. GRIEBLING TL
    Re: Safety and Feasibility of Robot-Assisted Radical Prostatectomy for Clinically Localized Prostate Cancer in Elderly Japanese Patients.
    J Urol. 2018;199:1375-1376.
    PubMed     Text format    

  21. GRIEBLING TL
    Re: Long-Term Survival of Patients Aged 80 Years or Older Treated with Radical Prostatectomy for Prostate Cancer.
    J Urol. 2018;199:1374.
    PubMed     Text format    


    PLoS Genet

  22. HAO Y, Bjerke GA, Pietrzak K, Melhuish TA, et al
    TGFbeta signaling limits lineage plasticity in prostate cancer.
    PLoS Genet. 2018;14:e1007409.
    PubMed     Text format     Abstract available


    Prog Urol

  23. MARTIN-MALBURET A, Marcq G, Leroy X, Guiffart P, et al
    [Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30092.
    PubMed     Text format     Abstract available

  24. HACHI K, Boualga K, Chettibi K, Harouni M, et al
    [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30094.
    PubMed     Text format     Abstract available


    Radiology

  25. CORNUD F, Roumiguie M, Barry de Longchamps N, Ploussard G, et al
    Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.
    Radiology. 2018 Jan 22:162916. doi: 10.1148/radiol.2017162916.
    PubMed     Text format     Abstract available

  26. PARK SY, Zacharias C, Harrison C, Fan RE, et al
    Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.
    Radiology. 2018 May 16:172232. doi: 10.1148/radiol.2018172232.
    PubMed     Text format     Abstract available

  27. THAI JN, Narayanan HA, George AK, Siddiqui MM, et al
    Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.
    Radiology. 2018 May 18:170425. doi: 10.1148/radiol.2018170425.
    PubMed     Text format     Abstract available


    Urology

  28. KAYE DR, Qi J, Morgan TM, Linsell S, et al
    Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30471.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: